Toward the development of podocyte-specific drugs.

Kidney International
J ReiserAndreas D Kistler

Abstract

Most kidney diseases that ultimately lead to end-stage renal failure originate within the glomerulus and are associated with proteinuria. Treatment options are unspecific and offer partial cures at best because available therapies do not primarily treat glomerular cells but rather act systemically and thus cause many side effects. Most glomerulopathies directly stem from injury to podocytes, cells that have a key role in the maintenance of the glomerular filter. Thus, these cells constitute an obvious and promising target for the development of novel kidney-protective drugs. During the last decade, enormous advances have been made in the understanding of podocyte structure and function. A number of pathways that are altered during glomerular diseases may be targeted by novel small- and large-molecule drugs as well as biologicals that have been identified in nephrology and other areas of drug development. Cultured podocytes provide a valuable model for high-throughput drug screening assays. Furthermore, podocytes have been shown to possess many features that make them particularly good target cells for renal protection. This mini-review discusses some of the most recent promising data related to potential drug therapy for protei...Continue Reading

References

Jan 1, 1981·Methods in Enzymology·A J Barrett, H Kirschke
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·T YamamotoW A Border
May 1, 1997·Journal of the American Society of Nephrology : JASN·P MundelW Kriz
Aug 17, 1999·Journal of Medicinal Chemistry·M A DechantsreiterH Kessler
Jan 5, 2000·Journal of the American Society of Nephrology : JASN·Jochen ReiserPeter Mundel
Feb 22, 2002·Journal of the American Society of Nephrology : JASN·Moin A SaleemPeter Mundel
Sep 14, 2002·Journal of Electron Microscopy·Keisuke InaYoshihisa Fujikura
Mar 6, 2003·The Journal of Clinical Investigation·Vera EreminaSusan E Quaggin
Jul 31, 2003·Biological Chemistry·Tobias LohmüllerThomas Reinheckel
May 18, 2004·The Journal of Clinical Investigation·Jochen ReiserPeter Mundel
Jan 14, 2005·Journal of the American Society of Nephrology : JASN·Iain A Drummond
Feb 3, 2005·Nature Reviews. Drug Discovery·Leonard I Zon, Randall T Peterson
Mar 31, 2006·The New England Journal of Medicine·Karl TryggvasonJorma Wartiovaara
Oct 13, 2006·American Journal of Physiology. Renal Physiology·Jeanette EyrePeter S Topham
Nov 3, 2006·Proceedings of the National Academy of Sciences of the United States of America·Tobias B HuberThomas Benzing
Dec 15, 2006·Journal of the American Society of Nephrology : JASN·Clemens C MöllerJochen Reiser
Apr 26, 2007·Kidney International·S J ShanklandP Mundel
Aug 3, 2007·The Journal of Clinical Investigation·Sanja SeverJochen Reiser
Dec 18, 2007·Nature Medicine·Changli WeiJochen Reiser
Jan 8, 2008·Current Hypertension Reports·Jochen Reiser, Peter Mundel
Jan 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shreeram AkileshAndrey S Shaw
Feb 8, 2008·Kidney International·K UchidaK Nitta
Mar 4, 2008·Nature Medicine·Thiruvur NiranjanKatalin Susztak
Mar 14, 2008·The New England Journal of Medicine·Vera EreminaSusan E Quaggin
Mar 18, 2008·Biology of the Cell·May C MorrisGilles Divita
Aug 30, 2008·American Journal of Nephrology·Hiroshi KajiyamaJeffrey B Kopp
Apr 7, 2009·Methods in Molecular Biology·W Frank An, Nicola J Tolliday
Jun 6, 2009·Journal of the American Society of Nephrology : JASN·Thomas Benzing
Jul 3, 2009·The New England Journal of Medicine·Laurence H BeckDavid J Salant

❮ Previous
Next ❯

Citations

Dec 17, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Shafic El Hindi, Jochen Reiser
Jun 11, 2011·Ultrastructural Pathology·Sihem DarouichAdel Kheder
Aug 16, 2011·Seminars in Nephrology·Alain Meyrier
Jul 26, 2011·Advances in Chronic Kidney Disease·Judit Gordon, Jeffrey B Kopp
Dec 7, 2010·Drug Discovery Today·Marco PrunottoSolange Moll
Jun 13, 2014·Genesis : the Journal of Genetics and Development·Paul T Kroeger, Rebecca A Wingert
Jun 23, 2015·Drug Discovery Today·Mark A LalUwe Andag
Apr 20, 2016·Clinical and Experimental Nephrology·Maho YamashitaMatsuhiko Hayashi
Sep 11, 2010·Advanced Drug Delivery Reviews·Jan Willem LeeuwisRoel Goldschmeding
Aug 28, 2016·Physiological Reports·Maho YamashitaMatsuhiko Hayashi
Oct 21, 2016·American Journal of Physiology. Renal Physiology·Vineet Gupta, Jochen Reiser
Feb 27, 2016·F1000Research·Jochen Reiser, Mehmet M Altintas
Apr 11, 2015·Journal of the American Society of Nephrology : JASN·Ha Won LeeVineet Gupta
Nov 27, 2014·Journal of the American Society of Nephrology : JASN·Shuta MotonishiReiko Inagi
Jan 24, 2019·American Journal of Physiology. Renal Physiology·Giuseppe Stefano NettiGiuseppe Grandaliano
Feb 21, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Meng WangZhaoyun Zhang
Nov 7, 2013·The Journal of Biological Chemistry·Andreas D KistlerJochen Reiser
Oct 20, 2017·American Journal of Physiology. Renal Physiology·Ha Won LeeVineet Gupta
Feb 1, 2012·Clinical Kidney Journal·Matthias Barton, Pierre-Louis Tharaux
Jan 16, 2021·Biochemical and Biophysical Research Communications·Guangrong HuHui Sun
Jul 10, 2021·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ryosuke FujiiKoji Suzuki
Jul 4, 2021·International Journal of Pharmaceutics·Nidhi RavalRakesh K Tekade
Oct 12, 2021·American Journal of Physiology. Renal Physiology·Shivangi AgarwalMehmet Mete Altintas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.